The atypical presentation of Felty syndrome, even without arthritis symptoms, needs further evaluation. Timely diagnosis of neutropenia and splenomegaly in patients with rheumatoid arthritis without joint symptoms is crucial for a better prognosis. Despite the rarity of the condition, clinicians should have a high index of suspicion, and multidisciplinary collaboration between rheumatology, hematology, and other specialists is required for accurate diagnosis.
Keywords: Felty syndrome; autoimmune neutropenia; hematology; rheumatology; rituximab.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.